Patent · US Active

Selective HDAC6 inhibitors

US9890136B2 · kind B2 · utility

3Cited by

6References

22Claims

0Family size

Assignee

THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK MEMORIAL SLOAN-KETTERING CANCER CENTER · US

Inventors

Ronald Breslow · Englewood, US
Paul A. Marks · Washington, US
Adaickapillai Mahendran · Brooklyn, US
Yuanshan Yao · Shanghai, CN

Key dates

Filing date	Dec 23, 2014
Grant date	Feb 13, 2018
Priority date	—
Expiry date	Dec 23, 2034

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07C259/10
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention provides a compound having the structure:

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.